PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Aprea Therapeutics, Inc. (APRE)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS03836J1025
CUSIP03836J102
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$28.62M
EPS-$3.95
PE Ratio0.54
Revenue (TTM)$583.23K
EBITDA (TTM)-$15.46M
Year Range$2.78 - $8.85
Target Price$15.67
Short %2.25%
Short Ratio12.20

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Aprea Therapeutics, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Aprea Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%December2024FebruaryMarchAprilMay
-98.76%
82.83%
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Aprea Therapeutics, Inc. had a return of 8.44% year-to-date (YTD) and 35.91% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date8.44%11.56%
1 month-4.74%7.13%
6 months35.91%17.26%
1 year35.91%26.92%
5 years (annualized)N/A13.56%
10 years (annualized)N/A10.87%

Monthly Returns

The table below presents the monthly returns of APRE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202410.00%63.64%-20.92%-23.77%8.44%
202351.51%-48.85%-13.45%-10.70%-2.90%-18.18%-1.59%19.35%12.61%-19.36%8.33%29.12%-29.00%
2022-27.18%-16.75%6.90%-21.51%-42.64%-10.45%28.00%-17.28%-18.15%3.06%-38.05%-20.24%-88.47%
202112.20%9.24%-15.42%-8.04%-10.02%15.64%-13.32%9.22%10.61%-3.13%-18.38%-28.96%-41.67%
2020-16.45%-10.54%1.34%-8.54%-15.51%44.38%-29.27%-1.20%-11.22%-9.35%15.73%-80.51%-89.28%
201917.80%4.27%82.25%123.85%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of APRE is 60, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of APRE is 6060
APRE (Aprea Therapeutics, Inc.)
The Sharpe Ratio Rank of APRE is 5757Sharpe Ratio Rank
The Sortino Ratio Rank of APRE is 6464Sortino Ratio Rank
The Omega Ratio Rank of APRE is 6060Omega Ratio Rank
The Calmar Ratio Rank of APRE is 6060Calmar Ratio Rank
The Martin Ratio Rank of APRE is 6161Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Aprea Therapeutics, Inc. (APRE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


APRE
Sharpe ratio
The chart of Sharpe ratio for APRE, currently valued at 0.38, compared to the broader market-2.00-1.000.001.002.003.004.000.38
Sortino ratio
The chart of Sortino ratio for APRE, currently valued at 1.26, compared to the broader market-4.00-2.000.002.004.006.001.26
Omega ratio
The chart of Omega ratio for APRE, currently valued at 1.14, compared to the broader market0.501.001.502.001.14
Calmar ratio
The chart of Calmar ratio for APRE, currently valued at 0.33, compared to the broader market0.002.004.006.000.33
Martin ratio
The chart of Martin ratio for APRE, currently valued at 1.56, compared to the broader market-10.000.0010.0020.0030.001.56
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.34, compared to the broader market-2.00-1.000.001.002.003.004.002.34
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.31, compared to the broader market-4.00-2.000.002.004.006.003.31
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.41, compared to the broader market0.501.001.502.001.41
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.90, compared to the broader market0.002.004.006.001.90
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.93, compared to the broader market-10.000.0010.0020.0030.008.93

Sharpe Ratio

The current Aprea Therapeutics, Inc. Sharpe ratio is 0.38. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Aprea Therapeutics, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
0.38
2.34
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Aprea Therapeutics, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-99.49%
0
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Aprea Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aprea Therapeutics, Inc. was 99.71%, occurring on Jul 10, 2023. The portfolio has not yet recovered.

The current Aprea Therapeutics, Inc. drawdown is 99.49%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.71%Dec 30, 2019887Jul 10, 2023
-24.77%Nov 20, 20195Nov 26, 20199Dec 10, 201914
-17.45%Dec 13, 20194Dec 18, 20194Dec 24, 20198
-8.92%Oct 22, 20197Oct 30, 201911Nov 14, 201918
-7.61%Oct 4, 20193Oct 8, 20198Oct 18, 201911

Volatility

Volatility Chart

The current Aprea Therapeutics, Inc. volatility is 15.70%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%December2024FebruaryMarchAprilMay
15.70%
3.10%
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aprea Therapeutics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items